|
|
|
|
LEADER |
02590nam a2200997Ia 4500 |
001 |
10-1016-j-jdcr-2021-11-012 |
008 |
220420s2022 CNT 000 0 und d |
020 |
|
|
|a 23525126 (ISSN)
|
245 |
1 |
0 |
|a Hidradenitis suppurativa in acute myeloid leukemia: Review of disease course and management
|
260 |
|
0 |
|b Elsevier Inc.
|c 2022
|
300 |
|
|
|a 4
|
856 |
|
|
|z View Fulltext in Publisher
|u https://doi.org/10.1016/j.jdcr.2021.11.012
|
650 |
0 |
4 |
|a abscess
|
650 |
0 |
4 |
|a acute
|
650 |
0 |
4 |
|a acute myeloid leukemia
|
650 |
0 |
4 |
|a adult
|
650 |
0 |
4 |
|a anthracycline
|
650 |
0 |
4 |
|a antibiotic agent
|
650 |
0 |
4 |
|a arm
|
650 |
0 |
4 |
|a Article
|
650 |
0 |
4 |
|a axilla
|
650 |
0 |
4 |
|a blood cell count
|
650 |
0 |
4 |
|a blood vessel occlusion
|
650 |
0 |
4 |
|a cancer patient
|
650 |
0 |
4 |
|a cefalexin
|
650 |
0 |
4 |
|a cefepime
|
650 |
0 |
4 |
|a ceftriaxone
|
650 |
0 |
4 |
|a chemotherapy
|
650 |
0 |
4 |
|a chill
|
650 |
0 |
4 |
|a chlorhexidine
|
650 |
0 |
4 |
|a clindamycin
|
650 |
0 |
4 |
|a clinical article
|
650 |
0 |
4 |
|a clinical feature
|
650 |
0 |
4 |
|a constipation
|
650 |
0 |
4 |
|a contusion
|
650 |
0 |
4 |
|a cytarabine
|
650 |
0 |
4 |
|a cytokine receptor antagonist
|
650 |
0 |
4 |
|a disease course
|
650 |
0 |
4 |
|a disease exacerbation
|
650 |
0 |
4 |
|a dyspnea
|
650 |
0 |
4 |
|a ertapenem
|
650 |
0 |
4 |
|a etretin
|
650 |
0 |
4 |
|a fatigue
|
650 |
0 |
4 |
|a febrile neutropenia
|
650 |
0 |
4 |
|a female
|
650 |
0 |
4 |
|a fever
|
650 |
0 |
4 |
|a flare
|
650 |
0 |
4 |
|a furunculosis
|
650 |
0 |
4 |
|a gingiva bleeding
|
650 |
0 |
4 |
|a hidradenitis
|
650 |
0 |
4 |
|a human
|
650 |
0 |
4 |
|a incision and drainage
|
650 |
0 |
4 |
|a induction
|
650 |
0 |
4 |
|a induction chemotherapy
|
650 |
0 |
4 |
|a inguinal region
|
650 |
0 |
4 |
|a interleukin 17
|
650 |
0 |
4 |
|a interleukin 23
|
650 |
0 |
4 |
|a leukemia
|
650 |
0 |
4 |
|a linezolid
|
650 |
0 |
4 |
|a liver dysfunction
|
650 |
0 |
4 |
|a male
|
650 |
0 |
4 |
|a marsupialization
|
650 |
0 |
4 |
|a medical procedures
|
650 |
0 |
4 |
|a middle aged
|
650 |
0 |
4 |
|a myeloid
|
650 |
0 |
4 |
|a neutrophil count
|
650 |
0 |
4 |
|a neutrophilia
|
650 |
0 |
4 |
|a outcome assessment
|
650 |
0 |
4 |
|a pain
|
650 |
0 |
4 |
|a pannus tissue
|
650 |
0 |
4 |
|a patient care
|
650 |
0 |
4 |
|a perineum
|
650 |
0 |
4 |
|a rifampicin
|
650 |
0 |
4 |
|a skin nodule
|
650 |
0 |
4 |
|a spironolactone
|
650 |
0 |
4 |
|a suppurativa
|
650 |
0 |
4 |
|a suppurative hidradenitis
|
650 |
0 |
4 |
|a treatment response
|
650 |
0 |
4 |
|a triamcinolone
|
650 |
0 |
4 |
|a vancomycin
|
700 |
1 |
0 |
|a Charrow, A.
|e author
|
700 |
1 |
0 |
|a Chen, S.X.
|e author
|
700 |
1 |
0 |
|a Kassamali, B.
|e author
|
700 |
1 |
0 |
|a Lopez, C.G.
|e author
|
700 |
1 |
0 |
|a Luskin, M.R.
|e author
|
773 |
|
|
|t JAAD Case Reports
|